Patents by Inventor Eric Deutsch
Eric Deutsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12644346Abstract: A system that can include slips configured to selectively engage a tubular string that extends into a wellbore, a slips lifter configured to selectively raise or lower the slips, and a link configured to decouple the slips from the slips lifter when the slips are rotated relative to the slips lifter. A method that can include operations of coupling a slips lifter, via a link, to slips on a rig floor, engaging the slips to a tubular, rotating the slips relative to the slips lifter, and decoupling the slips from the slips lifter by decoupling a first element of the link from a second element of the link in response to rotation of the slips.Type: GrantFiled: December 18, 2024Date of Patent: June 2, 2026Assignee: Nabors Drilling Technologies USA, Inc.Inventors: Eric Deutsch, Johnny Harris, Nathan Rose
-
Patent number: 12590949Abstract: The present invention proposes a radiomics-based biomarker for detecting the presence and the density of tumor infiltrating CD8 T-cells in a solid tumor without having to use any biopsy of said tumor. The invention also proposes to use this information to assess the immune phenotype of said solid tumor. In a particular embodiment, the invention proposes to prognose the survival and/or the treatment efficiency of cancer patients treated with immunotherapy such as anti-PD-1/PD-L1 monotherapy.Type: GrantFiled: July 13, 2018Date of Patent: March 31, 2026Assignees: Institut National de la Sante et de la Recherche Medicale, Universite Paris-SaclayInventors: Charles Ferte, Elaine Johanna Limkin, Roger Sun, Eric Deutsch
-
Publication number: 20260061029Abstract: Identification of effective targets alleviating the programmed cell removal (PrCR) of tumor cells by macrophages is of very high interest. The present inventors have identified that the cyclin-dependent kinase inhibitor p21 protein is a strong regulator of the macrophage-mediated PrCR. Also, they showed that the adoptive transfer of p21 overexpressing monocytes induces macrophage PrCR and transition from an anti-inflammatory to a pro-inflammatory phenotype in vivo, delays cancer progression and increases significantly the overall survival of mice engrafted with cancer cells. The present invention therefore concerns therapeutic compositions comprising monocytes that over-express the cyclin-dependent kinase inhibitor p21 protein, and their use for treating mammals suffering from cancer, especially leukemia.Type: ApplicationFiled: October 17, 2025Publication date: March 5, 2026Inventors: Jean-Luc PERFETTINI, Awatef ALLOUCH, Eric DEUTSCH
-
Patent number: 12514902Abstract: Identification of effective targets alleviating the programmed cell removal (PrCR) of tumor cells by macrophages is of very high interest. The present inventors have identified that the cyclin-dependent kinase inhibitor p21 protein is a strong regulator of the macrophage-mediated PrCR. Also, they showed that the adoptive transfer of p21 overexpressing monocytes induces macrophage PrCR and transition from an anti-inflammatory to a pro-inflammatory phenotype in vivo, delays cancer progression and increases significantly the overall survival of mice engrafted with cancer cells. The present invention therefore concerns therapeutic compositions comprising monocytes that over-express the cyclin-dependent kinase inhibitor p21 protein, and their use for treating mammals suffering from cancer, especially leukemia.Type: GrantFiled: July 17, 2020Date of Patent: January 6, 2026Assignee: Institut Gustave-RoussyInventors: Jean-Luc Perfettini, Awatef Allouch, Eric Deutsch
-
Patent number: 12511747Abstract: A method implemented by computer means for training a decision system for segmenting medical images from a training set of annotated medical images, the segments belonging to at least one class, each annotation of the medical images including quantitative information about a number of pixels of the image that belongs to each of the classes, the method using weakly-supervised algorithm based on a percentage of the pixels of the image belonging to a concerned class.Type: GrantFiled: March 11, 2022Date of Patent: December 30, 2025Assignees: INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SACLAY, CENTRALE SUPELECInventors: Marvin Lerousseau, Eric Deutsch
-
Publication number: 20250198244Abstract: A system that can include slips configured to selectively engage a tubular string that extends into a wellbore, a slips lifter configured to selectively raise or lower the slips, and a link configured to decouple the slips from the slips lifter when the slips are rotated relative to the slips lifter. A method that can include operations of coupling a slips lifter, via a link, to slips on a rig floor, engaging the slips to a tubular, rotating the slips relative to the slips lifter, and decoupling the slips from the slips lifter by decoupling a first element of the link from a second element of the link in response to rotation of the slips.Type: ApplicationFiled: December 18, 2024Publication date: June 19, 2025Inventors: Eric DEUTSCH, Johnny HARRIS, Nathan ROSE
-
Publication number: 20240346713Abstract: A computer-implemented method for reconstructing a 3D image of a human body part studied of a subject from at least one 2D projection of the human body part studied of the subject and a generative network trained for reconstructing 3D images. The human body part may be the head and/or the neck.Type: ApplicationFiled: April 12, 2024Publication date: October 17, 2024Applicants: THERAPANACEA, INSTITUT DE CANCEROLOGIE GUSTAVE ROUSSY, CENTRE LEON BERARDInventors: Alexandre CAFARO, Quentin SPINAT, Eric DEUTSCH, Vincent GREGOIRE, Nikos PARAGIOS
-
Publication number: 20240346668Abstract: A computer-implemented method for generating a registered image (Breg) based on at least one first image of an object compliant with a source imaging modality and on at least one second image of the object compliant with a target imaging modality. The object may include a human body part, and the structures of interest may include stiff regions such as bones, cartilage, or tendons.Type: ApplicationFiled: April 12, 2024Publication date: October 17, 2024Applicants: THERAPANACEA, INSTITUT DE CANCEROLOGIE GUSTAVE ROUSSY, CENTRE LEON BERARDInventors: Amaury LEROY, Eric DEUTSCH, Vincent GREGOIRE, Nikos PARAGIOS
-
Publication number: 20240153085Abstract: A method implemented by computer means for training a decision system for segmenting medical images from a training set of annotated medical images, the segments belonging to at least one class, each annotation of the medical images including quantitative information about a number of pixels of the image that belongs to each of the classes, the method using weakly-supervised algorithm based on a percentage of the pixels of the image belonging to a concerned class.Type: ApplicationFiled: March 11, 2022Publication date: May 9, 2024Applicants: INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SACLAY, CENTRALE SUPELECInventors: Marvin LEROUSSEAU, Eric DEUTSCH
-
Publication number: 20230218781Abstract: The present disclosure relates to the field of nanomedicine, in particular for treating cancers. The present disclosure more specifically provides new methods of treating undesirable M2-polarized macrophages and/or inducing M1 macrophage polarization in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of nanoparticles containing metallic elements.Type: ApplicationFiled: September 18, 2020Publication date: July 13, 2023Inventors: Awatef ALLOUCH, Eric DEUTSCH, Jean-Luc PERFETTINI, François LUX, Olivier TILLEMENT
-
Patent number: 11642691Abstract: A pipe doping apparatus comprises a bucket assembly including a base and a bucket supported on the base and having an inside volume, a lubricating unit having at least one lubricant applicator inside the bucket; and a source of torque configured to rotate the bucket and/or the lubricating unit relative to a tubular. The apparatus may include a cleaning unit and/or a drying unit and the source of torque may be a fluid jet in either. At least one lubricant applicator may be retractable and may be actuated between a retracted position and an extended position by centripetal force. The apparatus may further include a positioning assembly supporting the base and the rotary bucket assembly and a controller connected to and controlling each of:—the positioning assembly, the cleaning unit, the drying unit, and the lubricating unit.Type: GrantFiled: March 10, 2021Date of Patent: May 9, 2023Assignee: NABORS DRILLING TECHNOLOGIES USA, INC.Inventors: Ronald Schanlaub, Keith Hager, Chris Magnuson, Eric Deutsch
-
Patent number: 11603568Abstract: Although tumor-associated macrophages have been extensively studied in the control of response to radiotherapy, the molecular mechanisms involved in the ionizing radiation-mediated activation of macrophages remain elusive. Here the present inventors show that ionizing radiation induces the expression of interferon-regulatory factor 5 (IRF5) promoting thus macrophage activation toward a pro-inflammatory phenotype. They reveal that the activation of the Ataxia telangiectasia mutated (ATM) kinase is required for ionizing radiation-elicited macrophage activation, but also for macrophage reprogramming after treatments with ?-interferon, lipopolysaccharide or chemotherapeutic agent (such as cis-platin), underscoring the fact that the kinase ATM plays a central role during macrophage phenotypic switching toward a proinflammatory phenotype. They further demonstrate that NADPH oxidase 2 (NOX2)-dependent ROS production is upstream to ATM activation and is essential during this process.Type: GrantFiled: September 19, 2017Date of Patent: March 14, 2023Assignee: Institut Gustave RoussyInventors: Jean-Luc Perfettini, Eric Deutsch, Awatef Allouch
-
Publication number: 20230000801Abstract: A freeze-dried powder for preparing a thermogel including: from 1% to 35% of 2-[(3-aminopropyl)amino]ethanethiol or one of its pharmaceutically acceptable salt; from 40% to 85% of one or more poloxamer; and from 0.1% to 20% of one or more carbohydrate compound.Type: ApplicationFiled: November 24, 2020Publication date: January 5, 2023Applicants: CLEVEXEL PHARMA, INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SACLAYInventors: Denis BRICOUT, Xiuping WANG-ZHANG, Eric DEUTSCH, Céline CLEMENSON
-
Patent number: 11517575Abstract: The present invention is drawn to the use of Minaprine dihydrochloride and analogs thereof, for reducing tumor growth when administered to a patient suffering from cancer.Type: GrantFiled: January 23, 2019Date of Patent: December 6, 2022Assignee: Institut Gustave RoussyInventors: Jean Luc Perfettini, Eric Deutsch, Catherine Brenner, Jean-Christophe Cintrat, Frederic Taran
-
Patent number: 11471463Abstract: The present invention is drawn to the use of the compounds highlighted in Tables 1 & 2 and analogs thereof, for enhancing IR-mediated cellular cannibalism in cancer cells. Said compounds are herein called “enhancers of IR-mediated cellular cannibalism”. They can be used to enhance tumor immunogenicity and/or to induce a significant protective anticancer immune response in subjects that will receive or that have received a radiotherapy treatment. In other words, said compounds can be used to potentiate a radiotherapy treatment in a subject in need thereof. Said compounds are preferably chosen in the group consisting of: Mebhydroline 1,5-napthalene disulfonate salt, Flurbiprofen, Minaprine dihydrochloride, Myricetin, Digoxin, Digitoxin, Lanatoside, LOPA87, VP331, RN-1-026, SG6163F, VP450, and VP43.Type: GrantFiled: January 23, 2018Date of Patent: October 18, 2022Assignee: Institut Gustave RoussyInventors: Jean Luc Perfettini, Eric Deutsch, Catherine Brenner, Jean-Christophe Cintrat, Frederic Taran
-
Publication number: 20220257709Abstract: Identification of effective targets alleviating the programmed cell removal (PrCR) of tumor cells by macrophages is of very high interest. The present inventors have identified that the cyclin-dependent kinase inhibitor p21 protein is a strong regulator of the macrophage-mediated PrCR. Also, they showed that the adoptive transfer of p21 overexpressing monocytes induces macrophage PrCR and transition from an anti-inflammatory to a pro-inflammatory phenotype in vivo, delays cancer progression and increases significantly the overall survival of mice engrafted with cancer cells. The present invention therefore concerns therapeutic compositions comprising monocytes that over-express the cyclin-dependent kinase inhibitor p21 protein, and their use for treating mammals suffering from cancer, especially leukemia.Type: ApplicationFiled: July 17, 2020Publication date: August 18, 2022Applicant: Institut Gustave-RoussyInventors: Jean-Luc PERFETTINI, Awatef ALLOUCH, Eric DEUTSCH
-
Patent number: 11248424Abstract: A device and method for subterranean operations comprising a latch adapted to be coupled with a fingerboard of a drilling rig, the fingerboard including at least two fingers, wherein: the latch is selectively moveable between an open configuration and a closed configuration, the latch is adapted to selectively permit entrance of a first tubular into a tubular storage area between the at least two fingers when the latch is in the open configuration, and selectively maintain the first tubular in the tubular storage area when the latch is in the closed configuration, and the latch is spaced apart from the fingerboard.Type: GrantFiled: November 5, 2020Date of Patent: February 15, 2022Assignee: Nabors Drilling Technologies USA, Inc.Inventors: Christopher Magnuson, Alex Kunec, Eric Deutsch
-
Publication number: 20210187540Abstract: A pipe doping apparatus comprises a bucket assembly including a base and a bucket supported on the base and having an inside volume, a lubricating unit having at least one lubricant applicator inside the bucket; and a source of torque configured to rotate the bucket and/or the lubricating unit relative to a tubular. The apparatus may include a cleaning unit and/or a drying unit and the source of torque may be a fluid jet in either. At least one lubricant applicator may be retractable and may be actuated between a retracted position and an extended position by centripetal force. The apparatus may further include a positioning assembly supporting the base and the rotary bucket assembly and a controller connected to and controlling each of:—the positioning assembly, the cleaning unit, the drying unit, and the lubricating unit.Type: ApplicationFiled: March 10, 2021Publication date: June 24, 2021Inventors: Ronald SCHANLAUB, Keith HAGER, Chris MAGNUSON, Eric DEUTSCH
-
Patent number: 11021442Abstract: A process for the preparation of freeze-dried 2-[(3-aminopropyl)amino]ethanethiol including the following steps: a) the reaction of a solution of amifostine with a strong acid, to obtain a solution of 2-[(3-aminopropyl)amino]ethanethiol, and b) the freeze-drying of the solution of 2-[(3-aminopropyl)amino]ethanethiol, with or without addition of excipients.Type: GrantFiled: November 29, 2017Date of Patent: June 1, 2021Assignees: CLEVEXEL PHARMA, INSTITUT GUSTAVE ROUSSYInventors: Xiuping Wang-Zhang, Perrine Pivette, Karine Gonzalez, Eric Deutsch, Céline Clemenson
-
Publication number: 20210128730Abstract: The invention relates to methods for treating tumors. In particular, the invention provides novel use of nanoparticles in combination with ionizing radiations for treating tumors, wherein the combined effect of nanoparticles induces senescence and/or cannibalism of the tumor cells.Type: ApplicationFiled: July 4, 2018Publication date: May 6, 2021Inventors: François LUX, Olivier TILLEMENT, Jean-Luc PERFETTINI, Eric DEUTSCH, Frédéric LAW, Awatef ALLOUCH